Members only

Pioneering Technology

Pioneering Technology

Biosensors International operates globally, offering interventional devices and solutions for patients living with Coronary Artery Disease. We are proud of our track record and our continued innovation in the development of next-generation medical technologies, that make a difference to patients’ lives around the world.

Our global commercial teams together with a strong network of distributors, present and deliver our products where they can be of the greatest benefit. Complementing our established cardiovascular presence, our endovascular devices are offering more solutions for patients whose lives we touch.

Pioneering spirit led to Biosensors International developing its own Proprietary Technology in Biolimus A9™. The only limus drug designed specifically for coronary stent applications. BA9™ coated DES and DCS platforms, started a new stent generation that provides treatment solutions for previously neglected patients.

 

 

 

11881-000-EN - Rev.04

CAUTION: Please note that the following pages are exclusively reserved for Health Care Professionals in countries with applicable health authority product registrations. To the extent this site contains information intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions. Please contact your Biosensors International representative for availability or the products and registration status.

The law restricts these devices to sale by or on the order of a physician. Prior to use, it is important to read the "Instructions for Use" supplied with these devices for indications, contraindications, suggested procedures, warnings, and precautions.

Biosensors’ interventional cardiology products, including BioMatrix NeoFlex™, BioMatrix™ Alpha, BioFreedom™, BioFreedom™ Ultra, Chroma™, BioStream™, BMX-J®, BioPath™, Powerline™, RISE™ NC, are not available for sale in the United States and certain other countries. ALLEGRA™ is a product of NVT AG. Blue Sail Medical Co., Ltd is the parent company of NVT AG and Biosensors International Group, Ltd. and its affliates are collaborating for the commercialization of the ALLEGRA™ device.

BioMatrix NeoFlex, BioMatrix Alpha, BioFreedom, BioFreedom Ultra, Chroma, BioStream, BMX-J, BioPath, Juno, S-Stent, Powerline, Rise NC and Quadrature Link are trademarks or registered trademarks of Biosensors International Group, Ltd. ALLEGRA is a trademark or registered trademark of NVT AG. ALLEGRA™ is CE Mark approved (CE 0124). All other cited trademarks are the property of their respective owners.